Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Shares Issued (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Shares Issued for 4 consecutive years, with $53000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 108.8% to $53000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $173000.0 through Dec 2025, up 22.7% year-over-year, with the annual reading at $173000.0 for FY2025, 22.7% up from the prior year.
  • Shares Issued for Q4 2025 was $53000.0 at Century Therapeutics, down from $120000.0 in the prior quarter.
  • The five-year high for Shares Issued was $26.8 million in Q1 2022, with the low at -$26.6 million in Q3 2022.
  • Average Shares Issued over 4 years is $2.1 million, with a median of $124000.0 recorded in 2023.
  • The sharpest move saw Shares Issued plummeted 101.34% in 2023, then soared 108.8% in 2025.
  • Over 4 years, Shares Issued stood at $26.6 million in 2022, then tumbled by 101.34% to -$356000.0 in 2023, then crashed by 69.1% to -$602000.0 in 2024, then skyrocketed by 108.8% to $53000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $53000.0, $120000.0, and -$602000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.